⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LXEO News
Lexeo Therapeutics, Inc. Common Stock
Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM
globenewswire.com
LXEO
Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
globenewswire.com
LXEO
Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
globenewswire.com
LXEO
Form 8-K
sec.gov
LXEO
Apertura Gene Therapy to Provide Lexeo Therapeutics Access to TfR1 CapX™ for Program Designed to Treat Friedreich Ataxia
prnewswire.com
LXEO
Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
globenewswire.com
LXEO
Form 8-K
sec.gov
LXEO
Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations to Expand Leadership in Friedreich Ataxia
globenewswire.com
LXEO
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
globenewswire.com
LXEO
Form 8-K
sec.gov
LXEO